A Randomized, Double-Blind, Placebo-Controlled Trial of Weight Loss Using Liraglutide 3.0mg for Weight Recurrence after Roux-en-Y Gastric-Bypass
SURGERY FOR OBESITY AND RELATED DISEASES（2025）
关键词
Weight recurrence,Liraglutide,GLP-1 receptor agonist,Roux-en-Y gastric bypass,Bariatric surgery
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要